Thoracic Society of Australia and New Zealand position statement: The safe clinical use of sputum induction for bio-sampling of the lower airways in children and adults

Respirology. 2024 May;29(5):372-378. doi: 10.1111/resp.14707. Epub 2024 Mar 31.

Abstract

Sputum induction is widely used in clinical settings for collection of biological samples from the lower airways. However, in recent years sputum induction has been associated with serious adverse events and even death. This position statement was commissioned by the Thoracic Society of Australia and New Zealand to address major adverse events of two deaths associated with sputum induction that have occurred in Australia in 2021, and outlines best practice for the safe use of sputum induction. The statement resulted from systematic literature searches by a multi-disciplinary group including respiratory physicians, nurses and physiotherapists (paediatric and adults focused). Consumers had input to an advanced draft of the position statement. The position statement covers indications for sputum induction, informed consent, scope of practice of personnel administering the procedure, infection control considerations, details about the sputum induction procedure, safety considerations and risk assessment in clinical settings.

Keywords: adults; children; evidence base practice; hypertonic saline; sputum induction.

MeSH terms

  • Adult
  • Australia
  • Child
  • Forced Expiratory Volume
  • Humans
  • New Zealand
  • Saline Solution, Hypertonic
  • Sputum*

Substances

  • Saline Solution, Hypertonic